Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Soheila Korourian

Concepts (304)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
30
2018
1205
2.190
Why?
Carcinoma, Ductal, Breast
9
2015
89
1.440
Why?
Mastectomy, Segmental
8
2015
92
1.180
Why?
Catheter Ablation
4
2014
125
1.020
Why?
Neoplasm Recurrence, Local
7
2014
642
0.940
Why?
Sentinel Lymph Node Biopsy
15
2017
118
0.940
Why?
Mastectomy
10
2018
143
0.900
Why?
Mammary Neoplasms, Experimental
7
2010
122
0.810
Why?
Soybean Proteins
4
2023
162
0.780
Why?
Biopsy, Needle
11
2017
182
0.770
Why?
Obesity
8
2023
1164
0.760
Why?
Carcinoma in Situ
3
2008
72
0.740
Why?
Lymph Nodes
12
2017
252
0.720
Why?
Caseins
4
2023
78
0.700
Why?
9,10-Dimethyl-1,2-benzanthracene
4
2015
50
0.680
Why?
Liver
9
2023
1155
0.640
Why?
DNA, Neoplasm
1
2018
146
0.560
Why?
Isoflavones
5
2023
88
0.560
Why?
Rats, Zucker
9
2023
73
0.500
Why?
Uterine Cervical Neoplasms
3
2007
299
0.460
Why?
Receptor, erbB-2
3
2018
80
0.450
Why?
Aged
32
2018
10197
0.430
Why?
Receptors, Estrogen
4
2018
132
0.430
Why?
Arginine
1
2015
182
0.430
Why?
Dietary Supplements
2
2015
465
0.420
Why?
Neoplasm Staging
15
2015
767
0.410
Why?
Female
51
2018
28236
0.410
Why?
Middle Aged
34
2018
13094
0.410
Why?
Mammary Neoplasms, Animal
2
2015
33
0.380
Why?
Diet
2
2015
588
0.370
Why?
Ultrasonography, Mammary
4
2015
61
0.360
Why?
Carcinogens
3
2015
193
0.350
Why?
Antigens, Tumor-Associated, Carbohydrate
2
2008
24
0.350
Why?
Fatty Liver
3
2023
142
0.350
Why?
Benz(a)Anthracenes
1
2010
3
0.340
Why?
Dehydroepiandrosterone
1
2010
12
0.340
Why?
Rats
15
2023
3180
0.330
Why?
Axilla
9
2017
92
0.320
Why?
Lymphatic Vessels
4
2014
44
0.320
Why?
Aged, 80 and over
15
2018
3417
0.310
Why?
Adult
25
2018
14160
0.290
Why?
Plant Lectins
1
2008
8
0.290
Why?
Carcinoma, Ductal
1
2008
7
0.290
Why?
Prognosis
11
2017
2116
0.290
Why?
Magnetic Resonance Imaging
4
2014
1536
0.280
Why?
Technetium Tc 99m Sulfur Colloid
6
2014
31
0.280
Why?
Receptors, Progesterone
4
2018
66
0.270
Why?
Humans
48
2024
52539
0.270
Why?
Electrosurgery
1
2007
9
0.270
Why?
Clinical Competence
2
2024
400
0.270
Why?
Lymphedema
5
2017
48
0.260
Why?
Thinness
3
2017
44
0.260
Why?
Lymphatic Metastasis
12
2015
211
0.260
Why?
Cytodiagnosis
4
2015
42
0.250
Why?
Prospective Studies
12
2017
2453
0.250
Why?
Animals
19
2023
13465
0.250
Why?
Follow-Up Studies
10
2015
2293
0.240
Why?
Nipples
5
2013
33
0.240
Why?
Combined Modality Therapy
5
2014
638
0.240
Why?
Biopsy, Fine-Needle
4
2024
104
0.240
Why?
Adenocarcinoma, Mucinous
1
2005
20
0.230
Why?
Ethanol
5
2010
339
0.230
Why?
Endometritis
1
2004
9
0.230
Why?
Competency-Based Education
1
2024
28
0.220
Why?
Proteoglycans
1
2004
87
0.220
Why?
Radiopharmaceuticals
6
2014
205
0.220
Why?
Carcinoma, Intraductal, Noninfiltrating
3
2013
46
0.210
Why?
Proliferating Cell Nuclear Antigen
1
2003
68
0.210
Why?
Laser Coagulation
1
2003
27
0.210
Why?
Fellowships and Scholarships
1
2024
125
0.200
Why?
Membrane Glycoproteins
1
2004
241
0.200
Why?
Lymph Node Excision
6
2017
133
0.200
Why?
Plasma Cells
1
2004
239
0.200
Why?
Carcinoma, Lobular
3
2015
32
0.200
Why?
Neoplasm Invasiveness
5
2015
278
0.200
Why?
Coloring Agents
4
2014
68
0.200
Why?
Mammaplasty
2
2013
43
0.190
Why?
Infant Food
1
2002
28
0.190
Why?
Uterine Cervical Dysplasia
3
2007
51
0.190
Why?
Monitoring, Intraoperative
3
2014
52
0.180
Why?
Ovarian Neoplasms
1
2005
460
0.170
Why?
Immunohistochemistry
9
2017
981
0.170
Why?
Biopsy
4
2007
603
0.160
Why?
Ultrasonography, Interventional
3
2011
139
0.160
Why?
Paraffin Embedding
2
2018
52
0.160
Why?
Body Weight
3
2017
523
0.160
Why?
Sensitivity and Specificity
8
2015
883
0.160
Why?
Retrospective Studies
13
2015
6662
0.150
Why?
Lung Neoplasms
3
2015
633
0.150
Why?
Adolescent
8
2015
6727
0.150
Why?
Neoplasm Grading
3
2014
126
0.150
Why?
Tissue Fixation
1
2018
36
0.150
Why?
Specimen Handling
1
2018
56
0.140
Why?
Alanine Transaminase
3
2015
120
0.140
Why?
Rats, Sprague-Dawley
7
2015
1544
0.130
Why?
Treatment Outcome
5
2017
5484
0.120
Why?
Pulmonary Medicine
1
2015
14
0.120
Why?
Protein Hydrolysates
1
2015
7
0.120
Why?
Aspartate Aminotransferases
1
2015
50
0.120
Why?
Kaplan-Meier Estimate
2
2014
485
0.120
Why?
Sulfotransferases
1
2015
38
0.110
Why?
Rosaniline Dyes
1
2014
8
0.110
Why?
Image-Guided Biopsy
1
2015
34
0.110
Why?
Dermatologic Surgical Procedures
2
2013
35
0.110
Why?
Plant Extracts
1
2017
193
0.110
Why?
Melanoma
2
2011
279
0.110
Why?
Vacuum
2
2011
11
0.110
Why?
Young Adult
6
2015
4326
0.110
Why?
Ultrasonography, Doppler
1
2014
41
0.110
Why?
Interleukin-6
1
2015
277
0.110
Why?
Tumor Necrosis Factor-alpha
1
2015
395
0.100
Why?
Patient Care Planning
1
2013
68
0.100
Why?
Carcinoma, Adenoid Cystic
1
2013
5
0.100
Why?
Intraoperative Care
2
2011
51
0.100
Why?
Disease-Free Survival
1
2014
464
0.100
Why?
Preoperative Care
1
2014
174
0.100
Why?
Skin Neoplasms
2
2011
500
0.100
Why?
Lymphography
1
2011
8
0.090
Why?
Image Processing, Computer-Assisted
2
2003
243
0.090
Why?
Frozen Sections
1
2011
13
0.090
Why?
Liver Neoplasms
2
2005
333
0.090
Why?
DNA Methylation
1
2015
583
0.080
Why?
Cytoprotection
1
2010
33
0.080
Why?
Male
10
2023
26831
0.080
Why?
Fatty Liver, Alcoholic
1
2010
7
0.080
Why?
Drug Evaluation, Preclinical
1
2010
142
0.080
Why?
Genistein
1
2010
45
0.080
Why?
Feasibility Studies
1
2011
403
0.080
Why?
Cell Line, Tumor
3
2010
1435
0.080
Why?
Hepatocytes
2
2008
190
0.080
Why?
Pilot Projects
1
2011
719
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1030
0.070
Why?
Radionuclide Imaging
4
2011
107
0.070
Why?
Hepatitis
1
2008
20
0.070
Why?
Nuclear Magnetic Resonance, Biomolecular
1
2007
33
0.070
Why?
Cytokines
2
2008
624
0.070
Why?
Protons
1
2007
71
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2007
62
0.070
Why?
Ovariectomy
1
2007
113
0.070
Why?
Organ Size
1
2007
231
0.060
Why?
Oligosaccharides
1
2005
33
0.060
Why?
Cystadenocarcinoma, Papillary
1
2005
14
0.060
Why?
Antibodies, Neoplasm
1
2005
27
0.060
Why?
Aging
1
2010
707
0.060
Why?
Omentum
1
2005
16
0.060
Why?
Uterine Neoplasms
1
2005
59
0.060
Why?
Monosaccharide Transport Proteins
1
2004
14
0.060
Why?
Eosine Yellowish-(YS)
1
2004
6
0.060
Why?
Carcinoma, Small Cell
1
2004
26
0.060
Why?
Hematoxylin
1
2004
7
0.060
Why?
Syndecans
1
2004
37
0.060
Why?
Syndecan-1
1
2004
73
0.060
Why?
Endometrium
1
2004
43
0.060
Why?
Endotoxins
1
2004
22
0.060
Why?
Immunoenzyme Techniques
1
2004
136
0.060
Why?
Carbohydrates
1
2004
41
0.050
Why?
Lymphoma, Non-Hodgkin
1
2004
58
0.050
Why?
Pathology
1
2024
37
0.050
Why?
Liver Diseases, Alcoholic
1
2004
35
0.050
Why?
Cytological Techniques
1
2003
13
0.050
Why?
Apoproteins
1
2003
14
0.050
Why?
Neoplasms, Multiple Primary
1
2003
44
0.050
Why?
Fatty Acids
1
2004
151
0.050
Why?
Dietary Fats
1
2004
129
0.050
Why?
Malondialdehyde
1
2003
54
0.050
Why?
Gene Expression Regulation
1
2008
1004
0.050
Why?
Gene Expression
2
2019
623
0.050
Why?
Neoplasms
2
2004
1301
0.050
Why?
Cell Membrane
1
2004
241
0.050
Why?
Aldehydes
1
2003
81
0.050
Why?
Overweight
1
2005
224
0.050
Why?
Cytochrome P-450 CYP2E1
3
2010
111
0.050
Why?
Risk Factors
1
2011
3953
0.050
Why?
Surgical Instruments
1
2002
28
0.050
Why?
Breast Diseases
1
2002
25
0.050
Why?
Foreign-Body Migration
1
2002
31
0.050
Why?
Education, Medical, Graduate
1
2024
217
0.050
Why?
Hematoma
3
2010
68
0.050
Why?
Asia
1
2002
22
0.050
Why?
Chronic Disease
1
2004
588
0.050
Why?
Carcinoma, Squamous Cell
1
2004
330
0.050
Why?
Cost-Benefit Analysis
2
2015
269
0.040
Why?
Head and Neck Neoplasms
1
2004
288
0.040
Why?
Time Factors
1
2007
2997
0.040
Why?
Neoplasm Metastasis
2
2015
238
0.040
Why?
Health Status
1
2002
299
0.040
Why?
Cytokine Receptor Common beta Subunit
1
2019
2
0.040
Why?
Methyltransferases
1
2019
29
0.040
Why?
Apoptosis
1
2005
1122
0.040
Why?
Disease Progression
2
2015
872
0.040
Why?
Child, Preschool
1
2008
4058
0.040
Why?
Alcohol Dehydrogenase
2
2010
37
0.040
Why?
Cohort Studies
2
2015
1551
0.040
Why?
Arm
2
2009
47
0.040
Why?
Oxidative Stress
3
2010
809
0.040
Why?
Stereotaxic Techniques
2
2010
40
0.040
Why?
Polymerase Chain Reaction
1
2019
460
0.040
Why?
Anti-Bacterial Agents
1
2004
802
0.040
Why?
Risk Assessment
2
2017
1348
0.030
Why?
Adiponectin
1
2017
46
0.030
Why?
Disease Models, Animal
2
2015
1481
0.030
Why?
Reproducibility of Results
2
2015
1216
0.030
Why?
Injections, Intralesional
2
2008
32
0.030
Why?
Feces
1
2017
154
0.030
Why?
Phylogeny
1
2017
234
0.030
Why?
Lipid Metabolism
1
2017
188
0.030
Why?
Leptin
1
2017
147
0.030
Why?
Child
1
2008
7220
0.030
Why?
Cost Savings
1
2015
58
0.030
Why?
Protective Agents
1
2015
17
0.030
Why?
Taxoids
1
2015
38
0.030
Why?
MCF-7 Cells
1
2015
62
0.030
Why?
Mice, Inbred BALB C
2
2005
310
0.030
Why?
CpG Islands
1
2015
115
0.030
Why?
Insulin
1
2017
484
0.030
Why?
Infant, Newborn
1
2002
2884
0.030
Why?
Cyclophosphamide
1
2015
172
0.030
Why?
Tumor Cells, Cultured
1
2015
448
0.030
Why?
Touch
1
2013
24
0.030
Why?
Neoadjuvant Therapy
1
2015
125
0.030
Why?
Biopsy, Large-Core Needle
1
2013
33
0.030
Why?
Carcinoma
1
2015
137
0.030
Why?
Angiogenesis Inhibitors
1
2015
184
0.030
Why?
Infant
1
2002
3715
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2015
235
0.030
Why?
Radiotherapy, Adjuvant
1
2013
64
0.030
Why?
Hormones
1
2013
59
0.020
Why?
Chemotherapy, Adjuvant
1
2013
124
0.020
Why?
Injections, Intradermal
1
2011
14
0.020
Why?
X-Rays
1
2011
55
0.020
Why?
Antineoplastic Agents
2
2013
1219
0.020
Why?
United States
1
2002
5225
0.020
Why?
Cicatrix
1
2011
42
0.020
Why?
Intraoperative Period
1
2011
46
0.020
Why?
Diagnosis, Differential
2
2004
1045
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2015
856
0.020
Why?
Predictive Value of Tests
2
2004
949
0.020
Why?
Allyl Compounds
1
2010
11
0.020
Why?
Sulfides
1
2010
29
0.020
Why?
Survival Rate
1
2012
953
0.020
Why?
Chemokines
1
2010
78
0.020
Why?
Transforming Growth Factor beta1
1
2010
62
0.020
Why?
Double-Blind Method
1
2011
718
0.020
Why?
Mammary Glands, Animal
1
2010
69
0.020
Why?
Endoplasmic Reticulum
1
2010
113
0.020
Why?
Cell Division
1
2010
290
0.020
Why?
Pyrazoles
1
2010
114
0.020
Why?
Pregnancy
1
2015
2670
0.020
Why?
Tissue Extracts
1
2007
13
0.020
Why?
Least-Squares Analysis
1
2007
44
0.020
Why?
Enzyme Inhibitors
1
2010
371
0.020
Why?
Biotransformation
1
2007
86
0.020
Why?
Electrocoagulation
1
2007
12
0.020
Why?
Survival Analysis
1
2009
673
0.020
Why?
Solubility
1
2007
80
0.020
Why?
Observer Variation
1
2007
132
0.020
Why?
Staining and Labeling
1
2007
92
0.020
Why?
Enteral Nutrition
1
2008
155
0.020
Why?
Positron-Emission Tomography
1
2008
303
0.020
Why?
E-Selectin
1
2005
11
0.020
Why?
Body Weights and Measures
1
2005
17
0.020
Why?
Wheat Germ Agglutinins
1
2005
3
0.010
Why?
Vaccines, DNA
1
2005
11
0.010
Why?
Vaccines, Subunit
1
2005
15
0.010
Why?
Gadolinium
1
2005
44
0.010
Why?
Cross Reactions
1
2005
41
0.010
Why?
Growth Inhibitors
1
2005
26
0.010
Why?
Cytotoxicity, Immunologic
1
2005
57
0.010
Why?
Ligands
1
2005
207
0.010
Why?
Gene Amplification
1
2005
58
0.010
Why?
Mice
2
2005
5944
0.010
Why?
Glucose Transporter Type 1
1
2004
17
0.010
Why?
Imaging, Three-Dimensional
1
2005
151
0.010
Why?
Free Radicals
1
2004
28
0.010
Why?
Sampling Studies
1
2004
38
0.010
Why?
In Situ Hybridization, Fluorescence
1
2005
263
0.010
Why?
Enzyme Induction
1
2004
77
0.010
Why?
Contrast Media
1
2005
173
0.010
Why?
Corn Oil
1
2004
12
0.010
Why?
Eye Neoplasms
1
2004
8
0.010
Why?
MART-1 Antigen
1
2004
12
0.010
Why?
Hyperplasia
1
2004
98
0.010
Why?
Amino Acid Sequence
1
2005
571
0.010
Why?
Species Specificity
1
2004
191
0.010
Why?
Rats, Wistar
1
2004
190
0.010
Why?
Necrosis
1
2004
170
0.010
Why?
Cell Proliferation
1
2008
1027
0.010
Why?
Injections
1
2003
61
0.010
Why?
Molecular Sequence Data
1
2005
770
0.010
Why?
Dietary Carbohydrates
1
2004
90
0.010
Why?
Regression Analysis
1
2004
402
0.010
Why?
Cytoplasm
1
2004
93
0.010
Why?
Energy Intake
1
2004
173
0.010
Why?
Cytochrome P-450 Enzyme System
1
2004
191
0.010
Why?
Antigens, Neoplasm
1
2004
147
0.010
Why?
Cell Nucleus
1
2004
189
0.010
Why?
Multivariate Analysis
1
2004
602
0.010
Why?
Glutathione
1
2004
305
0.010
Why?
Sex Characteristics
1
2004
197
0.010
Why?
Antioxidants
1
2004
257
0.010
Why?
Confidence Intervals
1
2002
159
0.010
Why?
Models, Theoretical
1
2002
182
0.010
Why?
Neoplasm Proteins
1
2004
328
0.010
Why?
Reoperation
1
2002
466
0.010
Why?
Korourian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description